EUVIMEDEUVIMED entdecken
EditorialOpen Access

Advancing prostate cancer care through AI-driven multi-omics and biomarker-based strategies

Ishita Debnath, Moumita Kundu iD

Biomarkers in Medicine · 22.01.2026 · 20 (2) · 141-144

DOI: 10.1080/17520363.2026.2634063 ↗

Kurz gefasst

Editorial in der Zeitschrift Biomarkers in Medicine, online erschienen am 24.02.2026. Verfasst von Ishita Debnath und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Science & Technology, Birla Institute of Technology - Mesra, Ranchi, India. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AI-driven approachProstate-specific antigenbiomarkersdiagnosticprognosisprostate cancer

Autor:innen und Institutionen

  • Department of Pharmaceutical Science & Technology, Birla Institute of Technology - Mesra, Ranchi, India.
  • Center for Multidisciplinary Research & Innovations, Brainware University, Kolkata, India.
  • Department of Pharmaceutical Technology, Brainware University, Kolkata, India.

ORCID-Profile: Moumita Kundu

Zitieren

APA

Debnath, I., & Kundu, M. (2026). Advancing prostate cancer care through AI-driven multi-omics and biomarker-based strategies. Biomarkers in Medicine, 20(2), 141-144. https://doi.org/10.1080/17520363.2026.2634063

Vancouver

Debnath I, Kundu M. Advancing prostate cancer care through AI-driven multi-omics and biomarker-based strategies. Biomarkers in Medicine. 2026;20(2):141-144. doi:10.1080/17520363.2026.2634063

BibTeX
@article{Debnath2026,
  author = {Debnath, Ishita and Kundu, Moumita},
  title = {Advancing prostate cancer care through AI-driven multi-omics and biomarker-based strategies},
  journal = {Biomarkers in Medicine},
  year = {2026},
  volume = {20},
  number = {2},
  pages = {141--144},
  doi = {10.1080/17520363.2026.2634063}
}
Kostenlos starten →